Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions - Scorecard - MDSpire
Advertisement
Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions
Clinical Scorecard: Detection of Early Neural Shifts via Functional Magnetic Resonance Imaging: A Preliminary Investigation in Parkinson’s Disease Patients Receiving Istradefylline and Hybrid Assistive Limb Therapy
At a Glance
Category
Detail
Condition
Key Mechanisms
Istradefylline as an adenosine A2A receptor antagonist; Hybrid Assistive Limb (HAL) for motor enhancement. Clarify the specific neural pathways affected.
Target Population
Care Setting
Key Highlights
highlight_2
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
I
n
c
l
u
d
e
s
p
e
c
i
f
i
c
f
M
R
I
m
e
t
r
i
c
s
t
o
a
s
s
e
s
s
b
r
a
i
n
a
c
t
i
v
i
t
y
c
h
a
n
g
e
s
.
Risks
Patient & Prescribing Data
Include details on the duration and dosage of istradefylline therapy.
Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.
